Intrexon | XON - Чистый доход





Чистый доход Изменить Дата
Agenus USD -10.63M 74.49M 2025-12
Alaunos Therapeutics USD -1.16M 108K 2025-09
Amgen USD 1.33B 1.88B 2025-12
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD 30.81M 54.56M 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Incyte USD 299.28M 124.89M 2025-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Ligand Pharmaceuticals USD 117.27M 112.43M 2025-09
MacroGenics USD -14.16M 30.98M 2025-12
MannKind USD -15.95M 23.93M 2025-12
Merck USD 2.96B 2.82B 2025-12
Novartis USD 2.41B 1.52B 2025-12
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Roche Holding CHF 5.47B 1.76B 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Thermo Fisher Scientific USD 1.96B 348M 2025-12
Veracyte USD 41.15M 22.01M 2025-12
Xencor USD -6.65M 626K 2025-12